Patents by Inventor Carly Ziegler

Carly Ziegler has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240229166
    Abstract: The subject matter disclosed herein is generally directed to stratifying and treating coronavirus infections based on intrinsic immune states.
    Type: Application
    Filed: February 18, 2022
    Publication date: July 11, 2024
    Inventors: Alexander K. Shalek, Jose Ordovas-Montanes, Carly Ziegler, Sarah Glover, Bruce Horwitz, Vincent Miao, Anna Owings, Andrew Navia, Ying Tang, Joshua Bromley
  • Publication number: 20240132976
    Abstract: The subject matter disclosed herein is generally directed to stratifying and treating coronavirus infections based on intrinsic immune states.
    Type: Application
    Filed: February 18, 2022
    Publication date: April 25, 2024
    Inventors: Alexander K. Shalek, Jose Ordovas-Montanes, Carly Ziegler, Sarah Glover, Bruce Horwitz, Vincent Miao, Anna Owings, Andrew Navia, Ying Tang, Joshua Bromley
  • Publication number: 20240068057
    Abstract: Embodiments disclosed herein provide a pan-tissue cell atlas of healthy and diseased subjects obtained by single cell sequencing. The present invention discloses novel markers for cell types. Moreover, genes associated with disease, including HIV infection and tuberculosis are identified. The invention provides for diagnostic assays based on gene markers and cell composition, as well as therapeutic targets for controlling immune regulations and cell-cell communication of the cell types disclosed herein. In addition, novel cell types and methods of quantitating, detecting and isolating the cell types are disclosed.
    Type: Application
    Filed: August 21, 2023
    Publication date: February 29, 2024
    Inventors: Alexander K. Shalek, Carly Ziegler
  • Patent number: 11781193
    Abstract: Embodiments disclosed herein provide a pan-tissue cell atlas of healthy and diseased subjects obtained by single cell sequencing. The present invention discloses novel markers for cell types. Moreover, genes associated with disease, including HIV infection and tuberculosis are identified. The invention provides for diagnostic assays based on gene markers and cell composition, as well as therapeutic targets for controlling immune regulations and cell-cell communication of the cell types disclosed herein. In addition, novel cell types and methods of quantitating, detecting and isolating the cell types are disclosed.
    Type: Grant
    Filed: October 16, 2018
    Date of Patent: October 10, 2023
    Assignee: Massachusetts Institute of Technology
    Inventors: Alexander K. Shalek, Carly Ziegler
  • Patent number: 11680296
    Abstract: Gene expression signatures and pathways associated with tuberculosis are identified. The invention provides for diagnostic assays based on gene markers and cell composition, as well as therapeutic targets for modulating tuberculosis infection. In addition, tuberculosis copy number contained in cells and methods of detecting high and low copy number are disclosed.
    Type: Grant
    Filed: October 16, 2018
    Date of Patent: June 20, 2023
    Assignee: Massachusetts Institute of Technology
    Inventors: Alexander K. Shalek, Carly Ziegler
  • Publication number: 20210139990
    Abstract: Gene expression signatures and pathways associated with tuberculosis are identified. The invention provides for diagnostic assays based on gene markers and cell composition, as well as therapeutic targets for modulating tuberculosis infection. In addition, tuberculosis copy number contained in cells and methods of detecting high and low copy number are disclosed.
    Type: Application
    Filed: October 16, 2018
    Publication date: May 13, 2021
    Applicant: Massachusetts Institute of Technology
    Inventors: Alexander K. SHALEK, Carly ZIEGLER
  • Publication number: 20210024997
    Abstract: Embodiments disclosed herein provide a pan-tissue cell atlas of healthy and diseased subjects obtained by single cell sequencing. The present invention discloses novel markers for cell types. Moreover, genes associated with disease, including HIV infection and tuberculosis are identified. The invention provides for diagnostic assays based on gene markers and cell composition, as well as therapeutic targets for controlling immune regulations and cell-cell communication of the cell types disclosed herein. In addition, novel cell types and methods of quantitating, detecting and isolating the cell types are disclosed.
    Type: Application
    Filed: October 16, 2018
    Publication date: January 28, 2021
    Inventors: Alexander K. Shalek, Carly Ziegler, Shaina Carroll, Leslie Kean, Lucrezia Colonna
  • Publication number: 20200263264
    Abstract: Embodiments disclosed herein provide a pan-tissue cell atlas of healthy and diseased subjects obtained by single cell sequencing. The present invention discloses novel markers for cell types. Moreover, genes associated with disease, including HIV infection and tuberculosis are identified. The invention provides for diagnostic assays based on gene markers and cell composition, as well as therapeutic targets for controlling immune regulations and cell-cell communication of the cell types disclosed herein. In addition, novel cell types and methods of quantitating, detecting and isolating the cell types are disclosed.
    Type: Application
    Filed: October 16, 2018
    Publication date: August 20, 2020
    Inventors: Alexander K. Shalek, Carly Ziegler